Academic literature on the topic 'In-transit metastases'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'In-transit metastases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "In-transit metastases"

1

Kocatüurk, Emek, Pelin Kuteyla Ülkümen, Utkan Kizitaç, Tülin Yüksel, Ayşle Seza Kunter, and Selma Şlengiz Erhan. "In-Transit Metastasis from Primary Cutaneous Squamous Cell Carcinoma in a Nonimmunosuppressed Patient." Journal of Cutaneous Medicine and Surgery 19, no. 2 (2015): 167–70. http://dx.doi.org/10.2310/7750.2014.14047.

Full text
Abstract:
Background In-transit metastases are dermal and subcutanous metastatic foci located between the tumor and the closest regional lymph node. Although in-transit metastasis has been commonly described for malignant melanoma, there have been some reports of in-transit metastases arising from primary cutaneous malignancies. The risk of development of in-transit metastases is higher in patients with high-risk squamous cell carcinoma. Case Report We present a case of in-transit metastasis in a nonimmunosuppressed patient with a primary cutaneous squamous cell carcinoma.
APA, Harvard, Vancouver, ISO, and other styles
2

Lejeune, F. J. "In transit metastases." European Journal of Cancer 37 (April 2001): S252. http://dx.doi.org/10.1016/s0959-8049(01)81423-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Di Altobrando, Ambra, Federica Scarfì, Cosimo Misciali, Annalisa Patrizi, and Emi Dika. "In‐transit melanoma metastases." International Journal of Dermatology 58, no. 7 (2019): 844–45. http://dx.doi.org/10.1111/ijd.14377.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Costa, Sergio Renato Pais, Sergio Henrique Couto Horta, and Alexandre Cruz Henriques. "Popliteal lymphadenectomy for treating metastatic melanoma: case report." Sao Paulo Medical Journal 126, no. 4 (2008): 232–35. http://dx.doi.org/10.1590/s1516-31802008000400009.

Full text
Abstract:
CONTEXT: Regional lymph node involvement in patients with malignant melanomas has been associated with poor prognosis. In-transit metastases also lead to poor long-term survival. Whereas for nodal disease only regional lymphadenectomy offers adequate locoregional control, for in-transit metastasis both local excision and isolated limb perfusion with chemotherapy plus tumor necrosis factor-alpha can be used for disease control. In cases of tumors located in the distal region of the legs, the lymphatic dissemination most commonly observed is to the inguinal chain. Consequently, therapeutic ingui
APA, Harvard, Vancouver, ISO, and other styles
5

Queiroz, Marcello Moro, Eduardo Bertolli, Francisco Aparecido Belfort, and Rodrigo Ramella Munhoz. "Management of In-Transit Metastases." Current Oncology Reports 24, no. 5 (2022): 573–83. http://dx.doi.org/10.1007/s11912-022-01216-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Trapeznikov, N., and L. Demidov. "Management of in-transit metastases." Melanoma Research 3, no. 1 (1993): 31. http://dx.doi.org/10.1097/00008390-199303000-00106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Al-Mondhiry, Jafar, Chelsea Stahl, Suraj S. Venna, and Sekwon Jang. "Detection of ctDNA in patients with stage III cutaneous melanoma with satellite/in-transit or nodal metastases." Journal of Clinical Oncology 41, no. 16_suppl (2023): e21559-e21559. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e21559.

Full text
Abstract:
e21559 Background: Circulating tumor DNA (ctDNA) has emerged as a biomarker to monitor disease status in cancer patients. Limited data exists on the sensitivity of ctDNA for detection of satellite/in-transit or nodal metastases in melanoma. Methods: We conducted a retrospective study of stage III cutaneous melanomas with clinically detected satellite/in-transit and/or lymph node metastases who underwent ctDNA analysis using an mPCR-NGS-based ctDNA assay ("Signatera") prior to surgery or systemic therapy at Inova Schar Cancer Institute. Results: ctDNA was detected in 4 of 14 patients including
APA, Harvard, Vancouver, ISO, and other styles
8

Biswas, Bivas, Deepak Dabkara, and Sandip Ganguly. "In-transit metastases from malignant melanoma." National Medical Journal of India 30, no. 5 (2017): 297. http://dx.doi.org/10.4103/0970-258x.234405.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lee, Yunjae, Dongkyu Lee, Hyeonjung Yeo, Hannara Park, and Hyochun Park. "Extraordinarily aggressive cutaneous sarcomatoid squamous cell carcinoma of the face: a case report." Archives of Craniofacial Surgery 23, no. 2 (2022): 77–82. http://dx.doi.org/10.7181/acfs.2022.00059.

Full text
Abstract:
Sarcomatoid squamous cell carcinoma (SSCC), a biphasic malignant tumor consisting of atypical squamous epithelial and mesenchymal elements mixed with epithelioid and spindle cells, is a variant of squamous cell carcinoma. Cutaneous SSCC is very rare and aggressive and has a poor prognosis. Here, we report a case of cutaneous SSCC with satellites and in-transit metastases. A 79-year-old woman presented with a protruding mass on the left temporal area sized 1.2× 1.0 cm. The punch biopsy report indicated keratoacanthoma or well-differentiated squamous cell carcinoma. The size of the tumor increas
APA, Harvard, Vancouver, ISO, and other styles
10

Mikkelsen, Joachim, Anne Lene Hagen Wagenblast, Nille Behrendt, and Jørgen Lock-Andersen. "Melanoma in situ with in-transit metastases." JPRAS Open 11 (March 2017): 37–42. http://dx.doi.org/10.1016/j.jpra.2017.01.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "In-transit metastases"

1

Dinis, Inês Augusta Fernandes. "Tratamento de metástases em trânsito no melanoma." Master's thesis, 2019. http://hdl.handle.net/10316/89693.

Full text
Abstract:
Trabalho Final do Mestrado Integrado em Medicina apresentado à Faculdade de Medicina<br>Introdução: Metástases em trânsito (ITM) do melanoma maligno são lesões cutâneas e/ou subcutâneas localizadas a mais de 2 cm do tumor primário, entre este e os gânglios linfáticos locorregionais. Surgem em 5 a 10% dos doentes com melanoma. O estadiamento da AJCC de 2017 para o melanoma inclui-as nos estadios IIIB, IIIC e IIID. Ao longo dos anos, esta entidade tem vindo a salientar a sua importância prognóstica. Material e métodos: Este trabalho foi realizado através da seleção e consulta de artigos científi
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "In-transit metastases"

1

Clark, Jonathan R., and Douglas Shaw. "In-Transit Metastases." In Encyclopedia of Otolaryngology, Head and Neck Surgery. Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-23499-6_200161.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Brunstein, Flavia, Dirk J. Grünhagen, Timo ten Hagen, and Alexander M. M. Eggermont. "Isolated Limb Perfusion for Melanoma in Transit Metastases." In Regional Cancer Therapy. Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-225-0_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Liénard, D., F. Lejeune, and P. Ewalenko. "High dose of rTNFα with interferon-g and melphalan in isolation perfusion (ILP) for in transit melanoma metastases and recurrent soft tissue sarcoma." In Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy. Springer Paris, 1991. http://dx.doi.org/10.1007/978-2-8178-0782-9_63.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Terushkin, Vitaly, and John A. Carucci. "Management of Local Recurrence and In-Transit Metastasis." In High-Risk Cutaneous Squamous Cell Carcinoma. Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-47081-7_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Thompson, John F., Nicola Mozzillo, and Merrick I. Ross. "Local Melanoma Recurrence, Satellitosis, and In-transit Metastasis: Incidence, Outcomes, and Selection of Treatment Options." In Cutaneous Melanoma. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-46029-1_32-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Thompson, John F., Nicola Mozzillo, and Merrick I. Ross. "Local Melanoma Recurrence, Satellitosis, and In-transit Metastasis: Incidence, Outcomes, and Selection of Treatment Options." In Cutaneous Melanoma. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-05070-2_32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jinga, Dan-Corneliu, and Maria-Ruxandra Jinga. "Immunotherapy of Metastatic Melanoma." In Melanoma - Standard of Care, Challenges, and Updates in Clinical Research [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.105585.

Full text
Abstract:
Immunotherapy is part of the new treatments that significantly improved the prognostic of metastatic melanoma patients. The article reviews briefly the old immunotherapeutic approaches e.g., interferon-ᾳ2 and interleukin-2, and focuses on immune checkpoint inhibitors such as anti-CTLA-4 inhibitors and anti-PD-1 inhibitors in monotherapy or in combination (dual immune blockade). We detailed the results from CheckMate and KEYNOTTE clinical trials that lead to US Food and Drug Administration and European Medicines Agency approvals of the new agents for the treatment of advanced melanoma. The chap
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!